chr14-77296223-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_013382.7(POMT2):c.1057G>A(p.Gly353Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000185 in 1,457,072 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 31)
Exomes 𝑓: 0.000019 ( 0 hom. )
Consequence
POMT2
NM_013382.7 missense
NM_013382.7 missense
Scores
6
11
2
Clinical Significance
Conservation
PhyloP100: 7.82
Genes affected
POMT2 (HGNC:19743): (protein O-mannosyltransferase 2) The protein encoded by this gene is an O-mannosyltransferase that requires interaction with the product of the POMT1 gene for enzymatic function. The encoded protein is found in the membrane of the endoplasmic reticulum. Defects in this gene are a cause of Walker-Warburg syndrome (WWS).[provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 16 ACMG points.
PM1
In a domain MIR 1 (size 56) in uniprot entity POMT2_HUMAN there are 7 pathogenic changes around while only 0 benign (100%) in NM_013382.7
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.957
PP5
Variant 14-77296223-C-T is Pathogenic according to our data. Variant chr14-77296223-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 3231.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-77296223-C-T is described in Lovd as [Pathogenic]. Variant chr14-77296223-C-T is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POMT2 | NM_013382.7 | c.1057G>A | p.Gly353Ser | missense_variant | 9/21 | ENST00000261534.9 | NP_037514.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POMT2 | ENST00000261534.9 | c.1057G>A | p.Gly353Ser | missense_variant | 9/21 | 1 | NM_013382.7 | ENSP00000261534.4 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD3 exomes AF: 0.0000125 AC: 3AN: 240782Hom.: 0 AF XY: 0.0000154 AC XY: 2AN XY: 129684
GnomAD3 exomes
AF:
AC:
3
AN:
240782
Hom.:
AF XY:
AC XY:
2
AN XY:
129684
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1457072Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 724124
GnomAD4 exome
AF:
AC:
27
AN:
1457072
Hom.:
Cov.:
31
AF XY:
AC XY:
10
AN XY:
724124
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 08, 2024 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 01, 2006 | - - |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | May 26, 2009 | - - |
POMT2-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 01, 2022 | The POMT2 c.1057G>A variant is predicted to result in the amino acid substitution p.Gly353Ser. This variant was reported as causative in the compound heterozygous state in two patients with congenital muscular dystrophy with brain and eye anomalies (Mercuri et al. 2006. PubMed ID: 16701995; Godfrey et al. 2007. PubMed ID:17878207; Messina et al. 2008. PubMed ID: 18513969). This variant was observed in the homozygous or heterozygous states along with another pathogenic variant in three patients undergoing congenital muscular dystrophy testing at PreventionGenetics. This variant is reported in 0.0035% of alleles in individuals of South Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/14-77762566-C-T). This variant is interpreted as likely pathogenic. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 29, 2024 | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 19299310, 17878207, 11053679, 18513969, 16701995, 31589614, 32494558, 31069529, 35595449) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Pathogenic
Sift
Uncertain
D
Sift4G
Benign
T
Polyphen
D
Vest4
MutPred
Gain of catalytic residue at Y354 (P = 0.0044);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at